Amino Acid Substitutions at the Major Insertion Loop of Candida albicans Sterol 14alpha-Demethylase Are Involved in Fluconazole Resistance

被引:26
作者
Alvarez-Rueda, Nidia [1 ]
Fleury, Audrey [1 ]
Morio, Florent [1 ,2 ]
Pagniez, Fabrice [1 ]
Gastinel, Louis [3 ]
Le Pape, Patrice [1 ,2 ]
机构
[1] Univ Nantes, Nantes Atlantique Univ, Fac Pharm Nantes, Dept Parasitol & Mycol Med,IICiMed EA1155, Nantes, France
[2] CHU Nantes, Lab Parasitol Mycol, F-44035 Nantes 01, France
[3] Univ Limoges, INSERM UMR 850, Lab Pharmacol Immunosuppresseurs Transplantat, Limoges, France
关键词
LANOSTEROL; 14-ALPHA-DEMETHYLASE; AZOLE RESISTANCE; ASPERGILLUS-FUMIGATUS; MOLECULAR-MECHANISMS; 3-DIMENSIONAL MODEL; ANTIFUNGAL AGENTS; DRUG-RESISTANCE; PICHIA-PASTORIS; RISK-FACTORS; DEMETHYLASE;
D O I
10.1371/journal.pone.0021239
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: In the fungal pathogen Candida albicans, amino acid substitutions of 14alpha-demethylase (CaErg11p, CaCYP51) are associated with azole antifungals resistance. This is an area of research which is very dynamic, since the stakes concern the screening of new antifungals which circumvent resistance. The impact of amino acid substitutions on azole interaction has been postulated by homology modeling in comparison to the crystal structure of Mycobacterium tuberculosis (MT-CYP51). Modeling of amino acid residues situated between positions 428 to 459 remains difficult to explain to date, because they are in a major insertion loop specifically present in fungal species. Methodology/Principal Finding: Fluconazole resistance of clinical isolates displaying Y447H and V456I novel CaErg11p substitutions confirmed in vivo in a murine model of disseminated candidiasis. Y447H and V456I implication into fluconazole resistance was then studied by site-directed mutagenesis of wild-type CaErg11p and by heterogeneously expression into the Pichia pastoris model. CLSI modified tests showed that V447H and V456I are responsible for an 8-fold increase in fluconazole MICs of P. pastoris mutants compared to the wild-type controls. Moreover, mutants showed a sustained capacity for producing ergosterol, even in the presence of fluconazole. Based on these biological results, we are the first to propose a hybrid homology structure-function model of Ca-CYP51 using 3 different homology modeling programs. The variable position of the protein insertion loop, using different liganded or non-liganded templates of recently solved CYP51 structures, suggests its inherent flexibility. Mapping of recognized azole-resistant substitutions indicated that the flexibility of this region is probably enhanced by the relatively high glycine content of the consensus. Conclusions/Significance: The results highlight the potential role of the insertion loop in azole resistance in the human pathogen C. albicans. This new data should be taken into consideration for future studies aimed at designing new antifungal agents, which circumvent azole resistance.
引用
收藏
页数:11
相关论文
共 56 条
[21]   Treatment-related risk factors for hospital mortality in Candida bloodstream infections [J].
Labelle, Andrew J. ;
Micek, Scott T. ;
Roubinian, Nareg ;
Kollef, Marin H. .
CRITICAL CARE MEDICINE, 2008, 36 (11) :2967-2972
[22]   NUCLEOTIDE-SEQUENCE OF CYTOCHROME-P450 L1A1 (LANOSTEROL 14-ALPHA-DEMETHYLASE) FROM CANDIDA-ALBICANS [J].
LAI, MH ;
KIRSCH, DR .
NUCLEIC ACIDS RESEARCH, 1989, 17 (02) :804-804
[23]   Differential inhibition of human CYP3A4 and Candida albicans CYP51 with azole antifungal agents [J].
Lamb, DC ;
Kelly, DE ;
Baldwin, BC ;
Kelly, SL .
CHEMICO-BIOLOGICAL INTERACTIONS, 2000, 125 (03) :165-175
[24]   The mutation T315A in Candida albicans sterol 14 alpha-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity [J].
Lamb, DC ;
Kelly, DE ;
Schunck, WH ;
Shyadehi, AZ ;
Akhtar, M ;
Lowe, DJ ;
Baldwin, BC ;
Kelly, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (09) :5682-5688
[25]   Drug resistance genes and trailing growth in Candida albicans isolates [J].
Lee, MK ;
Williams, LE ;
Warnock, DW ;
Arthington-Skaggs, BA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (02) :217-224
[26]   Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains [J].
Loffler, J ;
Kelly, SL ;
Hebart, H ;
Schumacher, U ;
LassFlorl, C ;
Einsele, H .
FEMS MICROBIOLOGY LETTERS, 1997, 151 (02) :263-268
[27]   Heterologous protein production using the Pichia pastoris expression system [J].
Macauley-Patrick, S ;
Fazenda, ML ;
McNeil, B ;
Harvey, LM .
YEAST, 2005, 22 (04) :249-270
[28]   A novel mechanism of fluconazole resistance associated with fluconazole sequestration in Candida albicans isolates from a myelofibrosis patient [J].
Maebashi, K ;
Kudoh, M ;
Nishiyama, Y ;
Makimura, K ;
Uchida, K ;
Mori, T ;
Yamaguchi, H .
MICROBIOLOGY AND IMMUNOLOGY, 2002, 46 (05) :317-326
[29]   Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans [J].
Marichal, P ;
Koymans, L ;
Willemsens, S ;
Bellens, D ;
Verhasselt, P ;
Luyten, W ;
Borgers, M ;
Ramaekers, FCS ;
Odds, FC ;
Vanden Bossche, H .
MICROBIOLOGY-SGM, 1999, 145 :2701-2713
[30]   Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature [J].
Morio, Florent ;
Loge, Cedric ;
Besse, Bernard ;
Hennequin, Christophe ;
Le Pape, Patrice .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 66 (04) :373-384